Humana (HUM) Holder Omega Advisors Has Raised Its Holding by $15.38 Million as Valuation Rose; Stephens Investment Management Group Has Upped Its Idexx Labs (IDXX) Holding by $512,337

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Logo

Stephens Investment Management Group Llc increased its stake in Idexx Labs Inc (IDXX) by 0.86% based on its latest 2018Q2 regulatory filing with the SEC. Stephens Investment Management Group Llc bought 2,361 shares as the company’s stock rose 10.36% with the market. The institutional investor held 277,682 shares of the health care company at the end of 2018Q2, valued at $60.39 million, up from 275,321 at the end of the previous reported quarter. Stephens Investment Management Group Llc who had been investing in Idexx Labs Inc for a number of months, seems to be bullish on the $16.39B market cap company. The stock decreased 4.85% or $9.68 during the last trading session, reaching $190.01. About 620,485 shares traded or 13.29% up from the average. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 54.52% since December 8, 2017 and is uptrending. It has outperformed by 38.90% the S&P500.

Omega Advisors Inc increased its stake in Humana Inc (HUM) by 38.82% based on its latest 2018Q2 regulatory filing with the SEC. Omega Advisors Inc bought 51,800 shares as the company’s stock rose 8.21% with the market. The hedge fund held 185,253 shares of the medical specialities company at the end of 2018Q2, valued at $55.14M, up from 133,453 at the end of the previous reported quarter. Omega Advisors Inc who had been investing in Humana Inc for a number of months, seems to be bullish on the $41.98 billion market cap company. The stock decreased 3.25% or $10.27 during the last trading session, reaching $306. About 1.32 million shares traded or 71.62% up from the average. Humana Inc. (NYSE:HUM) has risen 29.98% since December 8, 2017 and is uptrending. It has outperformed by 14.36% the S&P500. Some Historical HUM News: 03/04/2018 – TriCare Earns Top Customer Experience Ratings for Health Plans, According to Temkin Group; 22/03/2018 – Humana Releases its 2018 Bold Goal Progress Report: More Healthy Days Achieved, Social Determinants of Health Addressed, and; 02/04/2018 – QUEST – CO, HUMANA, MULTIPLAN, UNITEDHEALTH GROUP’S OPTUM, UNITEDHEALTHCARE LAUNCH BLOCKCHAIN PROGRAM TO IMPROVE DATA QUALITY AMONG OTHERS; 05/04/2018 – MOODY’S: COST CONTROL MAIN BENEFIT OF INDUSTRY-SHIFTING VERTICAL INTEGRATION FOR US HEALTH INSURERS; 07/05/2018 – Humana at Deutsche Bank Health Care Conference Tomorrow; 21/03/2018 – KINDRED HEALTHCARE SAYS EGAN-JONES JOINS ISS IN RECOMMENDING KINDRED STOCKHOLDERS VOTE “FOR” TRANSACTION WITH TPG, WELSH, CARSON, ANDERSON & STOWE, HUMANA; 02/04/2018 – Shares of Anthem, UnitedHealth and Medicaid-provider Centene rise in premarket trading after sources confirm early deals talks between Walmart and Humana; 02/05/2018 – HUMANA 1Q ADJ EPS $3.36, EST. $3.20; 02/04/2018 – Baystreet.ca: Wal-Mart Buys Humana; 28/03/2018 – KINDRED HEALTHCARE SAYS DELAWARE COURT ALSO DENIED ALL RELIEF BRIGADE CAPITAL SOUGHT IN CONNECTION WITH ITS MOTION FOR PRELIMINARY INJUNCTION – SEC FILING

Investors sentiment increased to 1.02 in Q2 2018. Its up 0.24, from 0.78 in 2018Q1. It improved, as 22 investors sold HUM shares while 215 reduced holdings. 56 funds opened positions while 186 raised stakes. 121.65 million shares or 0.51% less from 122.28 million shares in 2018Q1 were reported. Hanson Doremus Invest holds 0.21% of its portfolio in Humana Inc. (NYSE:HUM) for 2,107 shares. Fiduciary Tru holds 1,378 shares. Captrust Finance Advsrs reported 177 shares. Prelude Cap Mgmt Limited Liability Com holds 1,159 shares or 0.02% of its portfolio. Fort Ltd Partnership holds 7.12% or 101,138 shares in its portfolio. Texas Permanent School Fund holds 0.14% or 33,599 shares. Cs Mckee Ltd Partnership owns 60,940 shares for 1.54% of their portfolio. Pinebridge Invests LP accumulated 0.02% or 2,465 shares. Bp Public Limited Com, United Kingdom-based fund reported 49,000 shares. Manufacturers Life Ins The has 0.05% invested in Humana Inc. (NYSE:HUM). 28,680 were accumulated by Nomura Holdg. Pub Employees Retirement Association Of Colorado, Colorado-based fund reported 25,561 shares. U S Glob Invsts invested 0.2% of its portfolio in Humana Inc. (NYSE:HUM). Virginia Retirement Et Al has invested 0.02% in Humana Inc. (NYSE:HUM). Waddell Reed owns 167,100 shares.

Omega Advisors Inc, which manages about $12.65B and $2.87B US Long portfolio, decreased its stake in Halcon Resources Corp by 351,000 shares to 350,000 shares, valued at $1.54 million in 2018Q2, according to the filing. It also reduced its holding in Shire Plc (NASDAQ:SHPG) by 289,372 shares in the quarter, leaving it with 122,500 shares, and cut its stake in Altisource Portfolio Solutions (NASDAQ:ASPS).

Among 23 analysts covering Humana (NYSE:HUM), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Humana had 95 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Humana Inc. (NYSE:HUM) earned “Outperform” rating by RBC Capital Markets on Friday, July 22. JP Morgan initiated the shares of HUM in report on Wednesday, September 16 with “Overweight” rating. Credit Suisse maintained the stock with “Neutral” rating in Friday, November 10 report. The firm has “Hold” rating given on Thursday, February 8 by RBC Capital Markets. Piper Jaffray maintained it with “Buy” rating and $31300 target in Tuesday, April 3 report. Argus Research maintained the stock with “Buy” rating in Monday, April 16 report. The firm earned “Outperform” rating on Friday, March 31 by IBC. Cowen & Co maintained Humana Inc. (NYSE:HUM) on Monday, January 29 with “Buy” rating. The stock of Humana Inc. (NYSE:HUM) has “Hold” rating given on Wednesday, May 2 by Cantor Fitzgerald. The stock of Humana Inc. (NYSE:HUM) has “Overweight” rating given on Thursday, November 8 by Morgan Stanley.

Since June 11, 2018, it had 0 insider purchases, and 9 insider sales for $31.43 million activity. 5,165 shares valued at $1.58M were sold by LeClaire Brian P. on Friday, June 15. BROUSSARD BRUCE D had sold 18,000 shares worth $5.92 million. On Thursday, November 8 the insider Huval Timothy S. sold $1.78 million. Another trade for 3,092 shares valued at $1.02 million was sold by Bierbower Elizabeth D. The insider Wheatley Timothy Alan sold 11,468 shares worth $3.43M. BILNEY JODY L sold 27,461 shares worth $8.42 million.

More notable recent Humana Inc. (NYSE:HUM) news were published by: Investorplace.com which released: “CVS Health Chooses a Different Strategy in Walgreens Drug Store War – Investorplace.com” on November 27, 2018, also Bizjournals.com with their article: “Humana execs to cash out millions in stock as shares jump to all-time high – Louisville Business First” published on November 12, 2018, Bizjournals.com published: “Humana invests in ClearData’s $26M funding round for health care cloud computing – Austin Business Journal” on November 20, 2018. More interesting news about Humana Inc. (NYSE:HUM) were released by: Bizjournals.com and their article: “KC pilot program may be tip of iceberg in Walgreens-Humana talks – Kansas City Business Journal” published on December 04, 2018 as well as Bizjournals.com‘s news article titled: “Humana accelerates $3B share buyback – Louisville Business First” with publication date: November 29, 2018.

Stephens Investment Management Group Llc, which manages about $3.08 billion and $4.98B US Long portfolio, decreased its stake in Tyler Technologies Inc (NYSE:TYL) by 3,596 shares to 226,003 shares, valued at $49.87M in 2018Q2, according to the filing. It also reduced its holding in Abiomed Inc (NASDAQ:ABMD) by 40,891 shares in the quarter, leaving it with 217,075 shares, and cut its stake in Q2 Hldgs Inc (NYSE:QTWO).

Investors sentiment increased to 1.01 in 2018 Q2. Its up 0.25, from 0.76 in 2018Q1. It improved, as 30 investors sold IDXX shares while 202 reduced holdings. 64 funds opened positions while 170 raised stakes. 71.88 million shares or 0.50% less from 72.24 million shares in 2018Q1 were reported. Quantbot Technologies Limited Partnership holds 0.23% or 15,506 shares in its portfolio. Ibm Retirement Fund invested in 0.08% or 1,645 shares. Guardian Life Insur Co Of America accumulated 0.01% or 240 shares. Efg Asset Mgmt (Americas) Corp holds 0.81% or 12,221 shares in its portfolio. Lau Associates Ltd Liability Co stated it has 1.91% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Mitchell Capital Mgmt Communication accumulated 18,663 shares or 1.47% of the stock. Oppenheimer And stated it has 2,600 shares or 0.02% of all its holdings. Assetmark Inc reported 0.11% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Utd Cap Finance Advisers Lc has 32,286 shares. Los Angeles Cap Mgmt And Equity holds 0.33% in IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 270,171 shares. Cortland Assocs Inc Mo, Missouri-based fund reported 28,355 shares. Parametric Assoc Limited Liability Corporation holds 261,156 shares. Marble Harbor Counsel Ltd Liability reported 2.11% stake. Regions Corporation holds 384 shares. Putnam Fl Invest Mngmt reported 4,849 shares stake.

Since August 21, 2018, it had 0 insider buys, and 6 insider sales for $15.75 million activity. $682,992 worth of stock was sold by HENDERSON REBECCA M on Tuesday, November 27. Lane Michael sold $1.44M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Tuesday, August 21. Shares for $2.76 million were sold by TWIGGE GIOVANI on Tuesday, August 21. 30,000 IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares with value of $7.37 million were sold by AYERS JONATHAN W.

More notable recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Nasdaq.com which released: “IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1 – Nasdaq” on May 04, 2018, also Nasdaq.com with their article: “IDEXX Laboratories (IDXX) Beats on Q1 Revenues, View Upbeat – Nasdaq” published on May 04, 2018, Nasdaq.com published: “IDEXX (IDXX) Hits a 52-Week High, Can the Run Continue? – Nasdaq” on May 07, 2018. More interesting news about IDEXX Laboratories, Inc. (NASDAQ:IDXX) were released by: Nasdaq.com and their article: “IDEXX Laboratories (IDXX) Beats on Q2 Earnings and Revenues – Nasdaq” published on August 01, 2018 as well as Globenewswire.com‘s news article titled: “Analysis: Positioning to Benefit within IDEXX Laboratories, Editas Medicine, Arconic, Cardtronics, Cloudera, and BMC Stock — Research Highlights Growth, Revenue, and Consolidated Results – GlobeNewswire” with publication date: November 12, 2018.

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 35 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity on Monday, November 5 with “Buy”. As per Monday, March 21, the company rating was maintained by Stifel Nicolaus. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Buy” rating given on Wednesday, August 23 by Bank of America. The rating was downgraded by Raymond James to “Market Perform” on Friday, August 28. The rating was maintained by Stifel Nicolaus with “Buy” on Tuesday, July 10. The stock has “Neutral” rating by Bank of America on Thursday, September 29. The firm has “Neutral” rating by CL King given on Friday, April 1. Stifel Nicolaus maintained it with “Buy” rating and $185.0 target in Monday, August 21 report. Credit Suisse maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) rating on Thursday, June 21. Credit Suisse has “Outperform” rating and $231 target. The rating was maintained by Stifel Nicolaus on Thursday, August 13 with “Buy”.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.